{
    "eid": "2-s2.0-85118275963",
    "title": "Imipenem dosing recommendations for patients undergoing continuous renal replacement therapy: systematic review and Monte Carlo simulations",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Urology",
            "@code": "2748",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Transplantation",
            "@code": "2747",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "AKI",
        "Critically ill patients",
        "CRRT",
        "Drug dosing",
        "Imipenem"
    ],
    "authors": [
        "Dhakrit Rungkitwattanakul",
        "Taniya Charoensareerat",
        "Pathakorn Kerdnimith",
        "Nutsinee Kosumwisaisakul",
        "Piyakamol Teeranaew",
        "Apinya Boonpeng",
        "Sutthiporn Pattharachayakul",
        "Nattachai Srisawat",
        "Weerachai Chaijamorn"
    ],
    "citedby-count": 1,
    "ref-count": 36,
    "ref-list": [
        "Pharmacokinetics of imipenem/ cilastatin in volunteers",
        "Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration",
        "Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America",
        "Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016",
        "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America",
        "The risk of seizures among the carbapenems: a meta-analysis",
        "Seizures as adverse events of antibiotic drugs: a systematic review",
        "Recommended \u03b2-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy",
        "Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'",
        "Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study",
        "KDIGO clinical practice guideline for acute kidney injury",
        "Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients",
        "A systematic review of antibiotic dosing regimens for septic patients receiving continuous renal replacement therapy: do current studies supply sufficient data?",
        "Population pharmacokinetics and simulations of imipenem in critically ill patients undergoing continuous renal replacement therapy",
        "Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration",
        "Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration",
        "Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD)",
        "Clinical validation of therapeutic drug monitoring of imipenem in spent effluent in critically ill patients receiving continuous renal replacement therapy: a pilot study",
        "Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients",
        "Pharmacokinetics and pharmacodynamics of imipenem and meropenem in critically ill patients treated with continuous venovenous hemodialysis",
        "Pharmacokinetics of imipenem/cilastatin burn intensive care unit patients undergoing high-dose continuous venovenous hemofiltration",
        "Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients",
        "Pharmacokinetics of imipenem and cilastatin during continuous venovenous hemodialysis in patients who are critically ill",
        "Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: lessons learned from an ancillary study of the IVOIRE trial",
        "Management of renal replacement therapy in ICU patients: an international survey",
        "Number of replications required in Monte Carlo simulation studies: a synthesis of four studies",
        "Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy",
        "A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy",
        "Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration",
        "Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy",
        "Doripenem dosing regimens in Asian critically ill patients with continuous renal replacement therapy",
        "We underdose antibiotics in patients on CRRT",
        "Prevention of resistance: a goal for dose selection for antimicrobial agents",
        "Pharmacodynamics of cefepime in patients with gram-negative infections"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Phayao",
            "@id": "60114221",
            "affilname": "University of Phayao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Washington, D.C.",
            "@id": "60012771",
            "affilname": "Howard University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012771",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pittsburgh",
            "@id": "60001361",
            "affilname": "University of Pittsburgh School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001361",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Siam University"
    ]
}